Ternary antifouling compositions and methods
US-9422433-B2 · Aug 23, 2016 · US
US2017190844A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017190844-A1 |
| Application number | US-201615389918-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 23, 2016 |
| Priority date | Jan 6, 2016 |
| Publication date | Jul 6, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A novel mussel-inspired injectable hydrogel with self-healing and anti-biofouling capabilities is developed, possessing great potential as drug delivery carrier. The hydrogel can heal autonomously from repeated structural damage and also effectively prevent nonspecific cell attachment and biofilm formation.
Opening claim text (preview).
1 . A polymer comprising at least one block A and one block B, where A is a thermo-responsive copolymer comprising at least one monomer having a lower critical solution temperature and at least one self-healing monomer and B is a hydrophilic polymer block. 2 . The polymer of claim 1 in which A is formed of a random copolymer. 3 . The polymer of claim 2 in which the random copolymer comprises DN where D is dopamine acrylamide and N is NIPAM. 4 . The polymer of claim 3 having the structure: 5 . The polymer of claim 1 in which the self-healing monomer is provided with a self-healing property at least in part by catechol groups. 6 . The polymer of claim 5 in which A is formed of a random copolymer. 7 . The polymer of claim 6 in which the random copolymer comprises DN where D is dopamine acrylamide and N is NIPAM. 8 . The polymer of claim 7 having the structure: 9 . The polymer of claim 5 in which the self-healing monomer is provided with a self-healing property at least in part by aromatic groups. 10 . The polymer of claim 9 in which A is formed of a random copolymer. 11 . The polymer of claim 10 in which the random copolymer comprises DN where D is dopamine acrylamide and N is NIPAM. 12 . The polymer of claim 11 having the structure:
containing polyether sequences · CPC title
Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title
Macromolecular gels · CPC title
Characterised by the use of unspecified macromolecular compounds, obtained otherwise than by polymerisation reactions only involving unsaturated carbon-to-carbon bonds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.